Skip to main content
World Today News
  • Home
  • News
  • World
  • Sport
  • Entertainment
  • Business
  • Health
  • Technology
Menu
  • Home
  • News
  • World
  • Sport
  • Entertainment
  • Business
  • Health
  • Technology
Market Survey Finds No South Korean Biometric Vendors in Global Healthcare Top Tier

Market Survey Finds No South Korean Biometric Vendors in Global Healthcare Top Tier

November 21, 2026 Health Desk Health

South Korea has no domestic suppliers listed among the leading vendors providing biometric authentication systems to the global healthcare sector, according to a market survey.

  • Zero Korean firms appear on the roster of 22 major biometric vendors serving healthcare.
  • Global incumbents NEC, Fujitsu, Thales, and IDEMIA are actively supplying Korean hospitals.
  • Adoption is driven by patient identification, EHR access control, and controlled-substance tracking.

The LinkedIn analysis examined two dozen companies positioned in the medical biometrics space, including NEC Corporation, Fujitsu Limited, Thales Group, IDEMIA, BIO-key International, Imprivata, Suprema Inc., HID Global, and ZKTeco. Not a single South Korean enterprise was identified among them, LinkedIn reported.

Despite the absence of local vendors on the global supplier list, foreign manufacturers are embedded in the Korean market. NEC and Fujitsu deploy advanced biometric recognition and data-security platforms to improve hospital operational efficiency. Thales provides data-protection and identity-management solutions tailored for medical institutions. IDEMIA supplies heightened biometric recognition for patient verification and medical-record access, actively using the Korean market, the survey noted.

The report contrasts the foreign vendors across four dimensions: technology, quality, price, and service.

Vendor Group Technical Position Quality Assessment Price/Service Profile
NEC, Fujitsu Advanced biometric portfolios High ratings Premium positioning
Thales, IDEMIA Global deployment experience Consistent quality Price-competitive
BIO-key, Imprivata Customization focus Service-oriented Tailored pricing
Suprema, M2SYS Cost-effective offerings Variable service quality Strong price competitiveness
ZKTeco, HID Global Balanced technology and cost Solid Gaining market share

Suprema Inc., despite its Korean-sounding name, is categorized alongside M2SYS as a price-competitive vendor with potential service-quality gaps, the survey shows.

Demand for biometric authentication in healthcare is rising across seven core use cases, the report states. Hospitals are deploying the technology for patient identification and verification, electronic health record access control, clinical-staff authentication, medication dispensing and controlled-substance access, medical-device security, facility and restricted-area entry, and telehealth or remote-patient authentication.

Additional growth vectors include health-insurance and billing-fraud prevention, pharmacy and prescription verification, and clinical-trial subject identification, the survey adds.

NEC’s platform integrates fingerprint and iris recognition with hospital information systems to meet audit-trail requirements. Fujitsu’s palm-vein scanners are marketed as contactless alternatives suited to infection-control protocols. Thales emphasizes hardware security modules that satisfy the commission’s encryption mandates.

With no domestic vendor on the global shortlist, Korean hospital procurement offices face a concentrated supplier base.

Suprema Inc. was founded in 2000 and listed on KOSDAQ in 2016. The company operates in more than 140 countries and reports that over one billion users rely on its technologies.

It holds the number-one market share in biometric access control across EMEA and has been named among the world’s top 50 security manufacturers. More than 40 percent of its workforce is engaged in research and development, with over 16 percent of annual sales reinvested in R&D.

Disclaimer: The information provided in this article is for educational and scientific communication purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider regarding any medical condition, diagnosis, or treatment plan.

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

More on this

  • Monitoring Required for Hepatitis B Risk When Switching to Injectable Cabotegravir/Rilpivirine
  • Google to Enforce Developer Verification for Android Apps From January 2027
  • Median Net Worth Peaks at 75+ in the Fed's Survey, but the Lead Is Thin (daybreakwire.com)
  • Beer and Spirits Linked to Higher Risk of Acute Kidney Injury, Study Finds (archyde.com)

Related

Search:

World Today News

World Today News is your trusted source for global journalism — breaking headlines, in-depth analysis, and reporting from around the world.

Quick Links

  • Privacy Policy
  • About Us
  • Accessibility statement
  • California Privacy Notice (CCPA/CPRA)
  • Contact
  • Cookie Policy
  • Disclaimer
  • DMCA Policy
  • Do not sell my info
  • EDITORIAL TEAM
  • Terms & Conditions

Browse by Location

  • GB
  • NZ
  • US

Connect With Us

© 2026 World Today News. All rights reserved. Your trusted global news source directory.
For contact, advertising, copyright, issues email: [email protected]

Privacy Policy Terms of Service